Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shuzhen Liu

Showing results (181-190 of 188) with videos related to

Pageof 19
Sort By:
You have reached the last page of results.This site can display upto 188 results.
Molecular Cancer|December 22, 2018
Alteration of tumor suppressor BMP5 in sporadic colorectal cancer: a genomic and transcriptomic profiling based studyErfei Chen, Fangfang Yang, Hongjuan He, et al.
BMC Medical Genomics|August 23, 2015
Development and verification of the PAM50-based Prosigna breast cancer gene signature assayBrett Wallden, James Storhoff, Torsten Nielsen, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 17, 2019
Immunogenicity of 2 and 3 Doses of the Quadrivalent Human Papillomavirus Vaccine up to 120 Months Postvaccination: Follow-up of a Randomized Clinical TrialRobine Donken, Simon R M Dobson, Kim D Marty, et al.
Science Advances|April 15, 2020
Eradication of tumor growth by delivering novel photothermal selenium-coated tellurium nanoheterojunctionsShiyou Chen, Chenyang Xing, Dazhou Huang, et al.
Breast Cancer Research and Treatment|January 2, 2015
Prognostic and predictive investigation of PAM50 intrinsic subtypes in the NCIC CTG MA.21 phase III chemotherapy trialShuzhen Liu, Judy-Anne W Chapman, Margot J Burnell, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 13, 2014
The PAM50 risk-of-recurrence score predicts risk for late distant recurrence after endocrine therapy in postmenopausal women with endocrine-responsive early breast cancerMartin Filipits, Torsten O Nielsen, Margaretha Rudas, et al.
Nature Communications|September 6, 2018
The prognostic effects of somatic mutations in ER-positive breast cancerObi L Griffith, Nicholas C Spies, Meenakshi Anurag, et al.
Nature Communications|November 16, 2018
Author Correction: The prognostic effects of somatic mutations in ER-positive breast cancerObi L Griffith, Nicholas C Spies, Meenakshi Anurag, et al.
Pageof 19

Showing results (181-190 of 188) with videos related to

Sort By:
Pageof 19
You have reached the last page of results.This site can display upto 188 results.
Molecular Cancer|December 22, 2018
Alteration of tumor suppressor BMP5 in sporadic colorectal cancer: a genomic and transcriptomic profiling based studyErfei Chen, Fangfang Yang, Hongjuan He, et al.
BMC Medical Genomics|August 23, 2015
Development and verification of the PAM50-based Prosigna breast cancer gene signature assayBrett Wallden, James Storhoff, Torsten Nielsen, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 17, 2019
Immunogenicity of 2 and 3 Doses of the Quadrivalent Human Papillomavirus Vaccine up to 120 Months Postvaccination: Follow-up of a Randomized Clinical TrialRobine Donken, Simon R M Dobson, Kim D Marty, et al.
Science Advances|April 15, 2020
Eradication of tumor growth by delivering novel photothermal selenium-coated tellurium nanoheterojunctionsShiyou Chen, Chenyang Xing, Dazhou Huang, et al.
Breast Cancer Research and Treatment|January 2, 2015
Prognostic and predictive investigation of PAM50 intrinsic subtypes in the NCIC CTG MA.21 phase III chemotherapy trialShuzhen Liu, Judy-Anne W Chapman, Margot J Burnell, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 13, 2014
The PAM50 risk-of-recurrence score predicts risk for late distant recurrence after endocrine therapy in postmenopausal women with endocrine-responsive early breast cancerMartin Filipits, Torsten O Nielsen, Margaretha Rudas, et al.
Nature Communications|September 6, 2018
The prognostic effects of somatic mutations in ER-positive breast cancerObi L Griffith, Nicholas C Spies, Meenakshi Anurag, et al.
Nature Communications|November 16, 2018
Author Correction: The prognostic effects of somatic mutations in ER-positive breast cancerObi L Griffith, Nicholas C Spies, Meenakshi Anurag, et al.
Pageof 19